INHALED CORTICOSTEROIDS IN PERSONS WITH HIV INFECTION: NOT THAT HARMLESS.

REFERENCES

• Hillebrand-Haverkort ME, Prummel MF, Ten Veen JH. Ritonavir-induced Cush-ing's syndrome in a patient treated with nasal fluticasone. AIDS 1999 Septem-ber 10; 13(13): 1803.
   Web of Science ®Google Scholar
• Foisy MM, Yakiwchuk EM, Chiu I, Singh AE. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 2008 July; 9(6): 389–396.
   PubMed Web of Science ®Google Scholar
• Gillett MJ, Cameron PU, Nguyen HV, Hurley DM, Mallal SA. latrogenic Cushing's syndrome in an HIV-infected patient treated with ritonavir and inhaled flutica-sone. AIDS 2005 April 29; 19(7): 740–741.
   PubMed Web of Science ®Google Scholar
• Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA. latrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immuno-deficiency virus-infected patients receiving inhaled corticosteroids and ritona-vir-boosted protease inhibitors: six cases. J Clin Endocrinol Metab 2005 July; 90(7): 4394–4398.
   PubMed Web of Science ®Google Scholar
• Soldatos G, Sztal-Mazer S, Woolley I, Stockigt J. Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction. Intern Med J2005 January; 35(1): 67–68.
   Google Scholar
• Valin N, De CN, Garrait V, Bergeron A, Bouche C, Molina JM. latrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature. J Int Assoc Physicians AIDS Care (Chic III ) 2009 March; 8(2): 113–121.
   Google Scholar
• Gray D, Roux P, Carrihill M, Klein M. Adrenal suppression and Cushing's syn-drome secondary to ritonavir and budesonide. S Afr Med J 2010 May; 100(5): 296–297.
   PubMed Web of Science ®Google Scholar
• Kedem E, Shahar E, Hassoun G, Pollack S. latrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. J Asthma 2010 September; 47(7): 830–831.
   PubMed Web of Science ®Google Scholar
• Abbott Laboratories Ltd. Norvir summary of product characteristics. 2005.
   Google Scholar
• Abbott Laboratories Ltd. Kaletra summary of product characteristics. 2005.
   Google Scholar
• Bristol-Myers Squibb Pharmaceuticals Ltd. Reyataz Summary of Product Char-acteristics. 2006.
   Google Scholar
• GlaxoSmithKline UK. Telzir Summary of Product Characteristics. 2006.
   Google Scholar
• Merck & Co Inc. Crixivan Prescribing Information. 2005.
   Google Scholar
• Roche Products Ltd. Invirase Summary of Product Characteristics. 2005.
   Google Scholar
• Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorti-coids. J Allergy Clin Immunol 1996 January; 97(1 Pt 2): 169–176.
   Web of Science ®Google Scholar
• Adams N, Lasserson TJ, Cates CJ, Jones PW. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children. Cochrane Database Syst Rev 2007; (4): CD002310.
   PubMed Web of Science ®Google Scholar
• Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002 May 15; 165(10): 1377–1383.
   PubMed Web of Science ®Google Scholar
• Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A sys-tematic review and meta-analysis. Arch Intern Med 1999 May 10; 159(9): 941–955.
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Bagg W, Thomas MG, Lucas JA, Ticehurst R, Black PN. Cushing's syn-drome due to interaction between inhaled corticosteroids and itraconazole. Ann Pharmacother 2004 January; 38(1): 46–49.
   PubMed Web of Science ®Google Scholar
• Dyer MJ, Halpin DM, Stein K. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. BMC Fam Pract 2006; 7:34.
   PubMedGoogle Scholar
• Guo Z, Gu Z, Howell SR et al. Ciclesonide disposition and metabolism: pharma-cokinetics, metabolism, and excretion in the mouse, rat, rabbit, and dog. Am J Ther 2006 November; 13(6): 490–501.
   Google Scholar